4,000 Recovered COVID-19 Church Members in South Korea Declare Donation of $83 Billion Worth Plasma for Cure”

South Korea: Chairman Lee Man-hee of Shincheonji Church of Jesus, the Temple of the Tabernacle of the Testimony (Shincheonji), sent a message to thank the Shincheonji members in Daegu who decided to donate their plasma needed in developing COVID-19 (novel coronavirus infection) vaccine.

The amount of blood being donated will be about $83 billion worth if the 4,000 patients donate 500ml individually, according to the current transaction in the United States. “It is difficult to accelerate developing a medicine for COVID-19 with only 200 recovered patients who expressed their will to donate blood. The massive donation from the recovered patients in the Shincheonji Church will solve the problem of the lack of blood for research,” said an official from Green Cross Pharma, a biopharmaceutical company in South Korea.

Shincheonji stated that Chairman Lee sent a one-page letter to thank the members. Through the letter titled, “To the beloved members of Daegu Church,” Chairman Lee said, “I was delighted upon hearing the news of your intent to actively participate in donating plasma (blood) for the development of the vaccine for the cure of COVID-19. I believe that you are the ones who received the blood of Jesus.”

He added, “I am very thankful to the Government, which took charge of preventing the spread of COVID-19 and providing treatment for it. This is not something our church could resolve,” and, “I know that you [Shincheonji members in Daegu] have gathered your hearts in our collective wish to free all the people of the world from the pains of this disease.”

Chairman Lee also stated through this message, “This is the work that needs to be done as citizens of this country and as true believers. It is keeping the command of Jesus of loving your neighbor as yourself (Mt 22:39), and I am thankful that you have gathered your hearts for this good work and in making this decision that is like the light,”

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *